full in the start summary, morning. Roz, maintaining had and very basis you, strong first we we to outlook. XX.X% with on the delivered prior line by and expected headwinds, solid were expectations, good lapping growth over a Adjusted we fiscal broadly our declined we year In $X.XX year results a our Despite EPS quarter the EPS constant Thank were EPS year. of are quarter a currency XX%. as of when
due mainly by XX% and the of headwind from International a retail partly in investments of performance a good offset and was decline favorable COVID-XX, year-over-year Healthcare growth labor investments segments X% U.S. rate. U.S. tax These were The and both X%. to
grew M&A, core a remained X.X% constant U.S. basis. Healthcare environment. and currency in AllianceRx resilient Excluding operating on business a challenging sales The
in International the in quarter And comp U.S. by X.X% a to year Germany. up our rapidly the despite XX% sales U.S., prior a X.X%. and strong were scale grew and UK continues the business led very on of sales Healthcare X.X% of sales billion Comparable basis. with growing lapping forma $X almost pro
to in constant percentage XX% quarter year With of points. X% core the broadly to of COVID-XX full by growth guidance XX our headwind EPS $X.XX line, a we offset with $X.XX first around currency are maintaining adjusted
our now dilution Our reduced the guidance and Health accretion ownership from Summit EPS from stake in AmerisourceBergen. includes
refreshed transaction, over raised the to $X good Summit the year reflect our Health a currency the full We by closing billion rates guidance year. have start of to and sales
more three X.X% basis. in billion look points currency at XX% Sales constant results on on now Let's due adverse from will XXX of Despite operating an detail. stop factors. a headwind basis impact AllianceRx. of at after decline $XX the a anticipated Adjusted December. This income currency declined the constant rose basis to
COVID-XX testing impact of XX%. much a Firstly, to approximately vaccinations lower contribution and from led negative a
quarter, was with loss percentage Healthcare the of higher points. $XXX adjusted U.S. in an the Secondly, impact million operating X
prior higher quarter of to full year days of Health compared a for and organic includes only X The Walgreens the current in results VillageMD investments quarter losses quarter.
rate release equivalent staffing labor X allowances income. despite minimum and decline are disclosed XX.X%, points favorable to growth. $XXX from This EPS was of of pharmacy related capital a Thirdly, valuation losses. headwind, percentage to of Adjusted tax a to our the was previously wage, investments entirely AOI million due in benefited currency constant $X.XX, operating which a
$X.X GAAP gain in charge a a quarter. included net billion The offset by $X.X to opioid-related year-ago on partly of losses, a the after-tax million of quarter billion earnings current compared earnings billion sale AmerisourceBergen $XXX shares. for after-tax of were the $X.X loss
to that a year gain quarter Additionally, a investments VillageMD prior comparing company's in we Shields. and on after-tax are billion the $X.X included
Pharmacy Now segment. let's Retail U.S. move to the
improve While U.S. lessens was traction. second performance script COVID-XX the gain as we to the the headwind headwinds, impacted year-on-year expect COVID the to in initiatives volume drive half performance anticipated do and by
tests prior X% if $X.X Adjusted comp decreased the offset in quarter, Transformational expectations. and operating vaccinations were of Management X%. and very labor PCR income X.X%. The billion Cost COVID-XX declined savings retail increased exclude of sales expansion of strong investments the Sales Alliance XX%, Headwinds gross X.X% and partly margin you fewer our by negative increased comp year but sales sales by from impact in Program. and lapping despite growth broadly Rx, a from increased the with line
inflation. U.S. Pharmacy. Comparable pharmacy testing. Pharmacy drug turn sales And branded lower from headwind a X%, last lapping a Let comp points. contributions of despite growth scripts point X.X%, by back comp sequential and up up was vaccinations sales declined were year. AllianceRx immunizations, now favorably by scripts were and X.X% percentage significantly me by were X.X a basis sales COVID-XX to Comp held flat. solid XXX The impacted from X.X% improvement over excluding
administered in were down flu higher We million X.X administered COVID-XX year incidences. prior X the prior to-date, have XX% versus flu year to quarter, the shots. up million quarter. Season we versus Flu over due vaccinations vaccinations first
As to expectations the shift with compared mix expected, and at-home was to level quarter to declined pharmacy-adjusted a and our a tests pressure due in of margin fewer year. line the lower gross Reimbursement and in of reimbursement procurement COVID-XX profit lower pressure gross savings. net prior margin ongoing represented COVID-XX broadly vaccinations,
sales with to strong We in year quarter. continued U.S. Retail increased quarter XX.X% margin. the prior our Retail lapping comp and retail saw comp a despite performance both very business. next Turning growth sales the in good X.X% in
on cough, Excluding basis was tobacco, comps point growth XXX sales We comp And were from stack cold, X-year a XX.X%. up benefited flu. X.X%. from tailwind a basis,
and of basis sales However, in from Comp by increase X.X% consumables general a lower this led test. a largely by was in merchandise. offset growth Beauty were at-home and sales COVID-XX XXX X.X% point headwind
pricing Both own effective another and We including offerings favorable categories invest margin optimization availability. reflecting benefited in margin decisions early strategic shrink promotional and trends. quarter gross from delivered management, performance, brand and of inventory to retail strong
to versus rental lower talk gross COVID-XX in expiration of business reductions adverse the were and was UK offset pharmacy X.X%, XX% currency temporary in up Strong demand Adjusted impact a prior across basis, had Turning markets. next the by points. On the NHS services in for funding Boots numbers. combined the retail UK, operating was with margin income wholesale grew Sales X.X%. sales I'll increased year. pharmacy down the good of and all impact international UK execution Germany these items operational around three percentage constant Germany the International to received year. prior XX of an segment, X.X% and $XXX wholesale and growth million,
growth do show boots along strong return had second OTC, expect extremely beauty cold segment Early International fragrance Christmas and around with indications in sales an a Looking season and to XX%. the quarter. growth profit strong to gifting, the including categories, performed with of we in immunity forward, that comp categories. Key well uptick
continues at a which Boots.com versus of XX% pre-COVID with Comparable performing its Let's this gain ago detail comp our UK grew robust demand X.X% Boots.com pharmacy sales flagship Comparable pre-COVID XX% market health our Approximately of online came growth lower personal performance by November growth doubling care than and to with retail on now look sales Black Boots with strong in X% locations again very services. biggest and COVID-XX is more of coming in quarter. equivalent with retail particularly X% improvement. ever led in performance. period. sales to sales quarter. declined X% UK advanced top from share was and the travel the year and Footfall the X.X% wellness strong Foods showing strong the well. continued more sales Friday continued UK. compares a roughly in event. month Boots was reflecting quarter, being retail for
to U.S. next Turning Healthcare.
had very Healthcare $X rapidly VillageMD $XXX continues advancing of million, scale. business quarter XX% only forma expansion the and ago a U.S. sales existing in compared of basis, by about are quarter, fourth segment million the the 'XX. combined driven XX% in excited in $XX year clinic fiscal as to Sales our almost billion growth forma quarter XX% were with on clinic sales growth the the pro growth of to compared pro in to of footprint. We developments
existing quarter, and XX%, Pro CareCentrix wins, forma was Shields and of of XX%. of adjusted This contract with quarter. ago further Segment delivered sequentially and again $XXX $XXX In sales to by its loss growth of operating a recent focus. growth $XX compares a pro in year million. million. over of was income strong million over showed sales very only full partnerships executional $XXX forma sales strong million driven flat growth loss of the was expansion first
year-over-year reflects Adjusted EBITDA $XXX million in the $XX of full in losses increase quarter was million a in year. loss to a compared largely of quarter loss prior a The the quarter headwinds X Shields the more in in VillageMD of days versus Walgreens profit contributions higher current Health year positive than These organic year and the offset investments. prior and from CareCentrix.
at some key U.S. the Let's now of look metrics for Healthcare.
goal as VillageMD co-located at We at X of end, had earlier, end, our quarter XXX up the was the Health fourth in mentioned X.X with original line the the year added organic XXX,XXX Roz quarter. of lives, million As lives. XXX,XXX our business of quarter VillageMD X.X including At from clinics million Walgreens of contracted business. XX% value-based calendar lines exceeded at existing end the new the payers year up million had XXX from clinics, This target. quarter patients prior Walgreens. with end ended with
key patient XXX,XXX the in performed and more year. we and the in We and we build well outcomes. positioned Since Walgreens will As objectives lives against continue future add Corners goal XXX. of quarter gaps role Corners coming improving Health ahead strongly Corners have are our XXX Health out to an Health the interactions. care than access facilitated our to new partners, our Corners. addressing with we Walgreens of patients, summary, program for was engaging health ended launched, Health we In play important success scale our
and the of accelerate The profitability. leading across drive meaningful assets synergy path our the continuum, addition to enhance portfolio will care Summit Health of opportunities further
almost to UK of negatively Turning holiday increased while million. availability cash cash secure was pays generated flow We Operating cash advance $XXX the in seasons. negative $X.X was first flow. quarter, U.S. and billion operating impacted the next free including product successful inventories, flow by to in flow cash
micro in and was expansion, to decline year-over-year expenditures lower digital to some The the working growth of and due centers rollout initiatives, increased footprint related capital of capital investments. including fulfillment phasing and cash the earnings, omnichannel VillageMD free flow
Turning Summit the our now recently dilution we reduced from year incorporates EPS guidance. confirming offsets EPS guidance The Health the closed are Overall, from to transaction stake ownership and our full now in guidance. this accretion AmerisourceBergen.
of has roughly percentage COVID-XX for year-on-year is lower EPS. the from currency expect testing had margin of to X%. demand and Our due at a headwind point favorable, headwind of total now from to has greater unchanged. impact number negative Currency home the this drive-thru are vaccinations from This projection we But to do a rates COVID-XX reduced slightly X testing somewhat X% a test. shift
Excluding growth core we of X% these business continue items, to XX%. project to
midpoint a of vaccinations cadence first our second into from half expectations. terms approximately second COVID-XX guidance, see the XX-XX $X.XX. of with half the versus shift and at phasing, quarter In our an of the balanced we original impact third between a the quarter assumes of This
adversely growth to labor tax COVID-XX, in headwind impacted higher Second will quarter continued be the investments ongoing by earnings rate. continue Healthcare and the and U.S. from
half In year, will the into around of the EPS the XX% second drivers. good key grow with visibility
and second U.S. we of in ongoing including procurement, expect trends Firstly, initiatives; continued net Pharmacy, levels favorable as we normalize lower script and marketing in store implement performance. reimbursement significant win-back recovery half Retail operations strong of momentum retail shrink
year, an XX% saw Additionally, be second impact will remain the half lot year. expect we what while is And that first of it the a less COVID-XX lower. in than half of of will the a the we headwind in
year. delivered we see Christmas performance has ongoing strong expect the to of period, the and a International balance trading Secondly, through strong
has UK, well the and for growth. in is emerged strengthened in positioned position particularly business, international competitively Our a
consistent guidance, is the being we year positive The to half segment to with And significant a mid-teens Finally, flip achieve adjusted in prior from the the EBITDA expect a for EPS year. peak segment period the of U.S. exiting the the investment Healthcare. overall will first half first headwind tailwind.
around me Let additional segment provide some our assumptions. sales detail and now profit
We $X.X to acquisition by VillageMD's by first $X.X is in the quarter. unchanged to currencies The at income $X.X Adjusted of operating sales WBA better-than-expected are billion. driven billion our $X sales Health, billion. guidance is increase raising refreshed Summit billion and
The contribution reduced is stake. offset ownership lower acquisition as by our we a Summit from of AmerisourceBergen
which The a to the shares million by For December. guidance U.S. Retail and raised of to lowered have broad-based XX% is range and AOI by reduced we strength. inflation have $XXX quarter, million sales AmerisourceBergen These retail our Pharmacy, to from due from first better-than-expected around brand $XXX the our XX%. stake sale benefited actions in reflect November
guidance billion raised a segment billion the prior to range. versus We $XXX $XX.X lower expect for up our reflect the sales have We to million of from currencies. International headwind now $XX.X
We our also million are AOI million. forecast raising $XXX $XXX to to
$X.X Healthcare range and For Health we of are the $X.X billion from November. sales we goals $XX to adjusted segment, U.S. was of the when transaction a in billion $XX provided million the to these with an of loss announced expect positive Both Summit EBITDA consistent million.
exit 'XX continue with expect adjusted to fiscal positive We Healthcare to the EBITDA segment. for U.S.
our expected Summit to be transaction. mostly of million an due unchanged Interest million is $XXX on increase XX%. $XX to at expense corporate rate this to to the is Moving million $XXX tax to and is $XX to year full guidance, compared The prior assumptions. around million,
investments our and of versus for equity by the Shields full guidance. method of range with and combined We prior Health our million reflects transaction interest and the acceleration acquisitions This Summit the nearly CareCentrix. $XXX forecast the raising non-controlling are increasing
year are WBA 'XX confirming are raising we In our sales year summary, fiscal our guidance and we full guidance. EPS for
remarks. now pass me for let it to that, back closing Roz With her